UVA

Kuva Space scores NASA contract, accelerates hyperspectral constellation ambitions

Doctor-turned-dealmaker reveals his M&A playbook

Dr. David Hung is pulling multiple financial levers to put Nuvation Bio on strong footing as it advances its oncology drugs.

Merck (MRK) Wins FDA Expansions, Posts HIV Data, And Ends Lung Cancer Trial

Merck (NYSE:MRK) received FDA approval for expanded use of KEYTRUDA and KEYTRUDA QLEX with WELIREG as adjuvant treatment in certain renal cell carcinoma patients. The FDA also granted expanded approval for CAPVAXIVE in children and adolescents at higher risk for pneumococcal disease, making it the only PCV indicated for this US group. Merck and Gilead reported positive Phase 3 data for a once weekly oral HIV treatment regimen. Separately, Merck discontinued a Phase 3 lung cancer trial...

UVA-ReLeaf study finds preserving mature trees can outperform stock market

Here’s Why Merck (MRK) is Among the 10 Undervalued Counter Cyclical Stocks to Buy Now

Merck & Co., Inc. (NYSE:MRK) is one of the 10 Undervalued Counter Cyclical Stocks to Buy Now. On June 12, 2026, Merck & Co., Inc. (NYSE:MRK) announced that the U.S. Food and Drug Administration approved KEYTRUDA and KEYTRUDA QLEX, each in combination with WELIREG, for the adjuvant treatment of adult patients with renal cell carcinoma […]

15-year-old boy found dead in Park DuValle neighborhood; LMPD investigating